CABANA: underpowered and with detrimental protocol changes: is 'ablation salvation'?-Reply by the authors of the CABANA trial

Europace. 2022 Jan 4;24(1):3. doi: 10.1093/europace/euab237.
No abstract available

Publication types

  • Comment

MeSH terms

  • Anti-Arrhythmia Agents / therapeutic use
  • Catheter Ablation* / adverse effects
  • Catheter Ablation* / methods
  • Humans

Substances

  • Anti-Arrhythmia Agents